|
Manzanedo I, Pereira F, Cascales-Campos P, Munoz-Casares C, Asensio E, Torres-Melero J, Prada-Villaverde A, Caravaca-Garcia I, Gutierrez-Calvo A, Vaque J, Ortega G, Titos-Garcia A, Gonzalez-Sanchez L, Perez-Viejo E, Serrano A, Martinez-Torres B, Regecop Group. Treatment of Peritoneal Surface Malignancies by Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Spain: Results of the National Registry of the Spanish Group of Peritoneal Oncologic Surgery (REGECOP). J Clin Med. 2023 May 31;12(11):3774. doi: 10.3390/jcm12113774. PubMed PMID: 37297969; PubMed Central PMCID: PMC10253421.
AÑO: 2023; IF: 3.0
|
|
Lopez-Lopez, V; Hiciano-Guillermo, A; Martinez-Alarcon, L; Delegido, A; Alconchel, F; Pons, JA; Cascales-Campos, P; Miura, K; Baroja, A; Sanchez-Bueno, F; Robles-Campos, R; Ramirez, P. Postoperative negative-pressure incision therapy after liver transplant (PONILITRANS study): a randomized controlled trial. TRANSPLANTATION. 2023; 107(9):285-285.
AÑO: 2023; IF: 5.3
|
|
Lopez-Lopez V, Miura K, Kuemmerli C, Capel A, Eshmuminov D, Ferreras D, Baroja-Mazo A, Cascales-Campos P, Jimenez-Mascunan MI, Pons JA, Castellon MI, Sanchez-Bueno F, Robles-Campos R, Ramirez P. Selecting the Appropriate Downstaging and Bridging Therapies for Hepatocellular Carcinoma: What Is the Role of Transarterial Radioembolization? A Pooled Analysis. Cancers (Basel). 2023 Apr 2;15(7):2122. doi: 10.3390/cancers15072122. PubMed PMID: 37046783; PubMed Central PMCID: PMC10093460.
AÑO: 2023; IF: 4.5
|
|
Grávalos C., Pereira F., Vera R., Arjona-Sánchez A., Losa F., Ramos I., García-Alfonso P., Gonzalez-Bayón L., Cascales-Campos P.A., Aranda E. Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statement. Clinical and Translational Oncology. December 2023. 25:3378-3394. 10.1007/s12094-023-03204-7
AÑO: 2023; IF: 2.8
|
|
Llueca A, Ibanez MV, Cascales P, Gil-Moreno A, Bebia V, Ponce J, Fernandez S, Arjona-Sanchez A, Muruzabal JC, Veiga N, Diaz-Feijoo B, Celada C, Gilabert-Estelles J, Aghababyan C, Lacueva J, Calero A, Segura JJ, Maiocchi K, Llorca S, Villarin A, Climent MT, Delgado K, Serra A, Gomez-Quiles L, Llueca M, On Behalf Of Spain Gog And Gecop Working Group. Neoadjuvant Chemotherapy plus Interval Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy (NIHIPEC) in the Treatment of Advanced Ovarian Cancer: A Multicentric Propensity Score Study. Cancers (Basel). 2023 Aug 26;15(17):4271. doi: 10.3390/cancers15174271. PubMed PMID: 37686547; PubMed Central PMCID: PMC10486645.
AÑO: 2023; IF: 4.5
|